Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 3 of 5 peers filed FY2024. Switch to FY2023 (4 of 5).
| Line item | Alergiisa Da Imunologii… | Inovatsiuri Sameditsino… | Estetikis Tsentri MM | Med-Diagnostika | Kartul-Amerikuli Reprod… |
|---|---|---|---|---|---|
| Total Revenue | 5,854 | 5,256 | 4,831 | — | — |
| Total COGS | -2,755 | -3,371 | -1,920 | — | — |
| Gross Profit | 3,100 | 1,885 | 2,912 | — | — |
| Gross Margin | 52.9% | 35.9% | 60.3% | — | — |
| Total Operating Expenses | -1,253 | -1,491 | -1,636 | — | — |
| EBITDA | 1,847 | 395 | 1,276 | — | — |
| EBITDA Margin | 31.6% | 7.5% | 26.4% | — | — |
| Total D&A | -206 | -98 | -160 | — | — |
| EBIT / Operating Income | 1,641 | 296 | 1,116 | — | — |
| Total Interest Income | 1 | — | — | — | — |
| Total Interest Expense | -192 | — | -13 | — | — |
| Total Other Income | 18 | 16 | -39 | — | — |
| Profit Before Tax | 1,468 | 313 | 1,064 | — | — |
| Total Income Tax | 0 | 0 | -104 | — | — |
| Net Profit / (Loss) | 1,468 | 313 | 960 | — | — |
| Net Margin | 25.1% | 5.9% | 19.9% | — | — |
Not every picked company reports every selected year — FY2024: no filing for Med-Diagnostika and Kartul-Amerikuli Reprod…. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Alergiisa Da Imunologii… | Healthcare Services | 31.6% | 91st pct | 268 |
| Estetikis Tsentri MM | Healthcare Services | 26.4% | 87th pct | 268 |
| Inovatsiuri Sameditsino… | Healthcare Services | 7.5% | 43rd pct | 268 |
| Med-Diagnostika | Healthcare Services | — | no FY data | 268 |
| Kartul-Amerikuli Reprod… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.